SMTL ID : 9c56.1

Crystal structure of human PTPN2 in complex with allosteric inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.43 Å

Oligo State

monomer

Ligands

1 x FRJ: 3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE

FRJ.1: 13 residues within 4Å: Chain A: P.190, A.191, L.194, N.195, F.198, K.199, E.202, E.275, G.276, K.278, C.279, I.280, K.281 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.191, A:L.194, A:F.198, A:F.198, A:F.198, A:K.278, A:I.280 Hydrogen bonds: A:E.275, A:E.275

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bester, S.M. et al., Enhancing the apo protein tyrosine phosphatase non-receptor type 2 crystal soaking strategy through inhibitor-accessible binding sites. Acta Crystallogr.,Sect.F (2024)

Release Date

2024-09-04

Peptides

Tyrosine-protein phosphatase non-receptor type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 2

Related Entries With Identical Sequence